For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for Canadian Imperial Bank of Commerce (CM) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-09-11): Designation Gem · Gem Score +40 (−100…+100 Quality+Value blend) · Quality 45 · Value 36 · Sentiment -23 (timing only, not weighted) · Composite fair value $143.96 vs $114.93 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
Canadian Imperial Bank of Commerce
CM NYSECanadian Imperial Bank of Commerce is a major Canadian financial institution that provides personal banking, business banking, commercial banking, wealth management, and capital markets services. Canadian Imperial Bank of Commerce serves individuals, small businesses, corporate clients, public sector organizations, and institutional investors through a broad range of products that includes deposits, lending, mortgages, credit cards, cash management, investment solutions, brokerage, and treasury services. The bank also offers cross-border banking and specialized support for clients with operations in Canada and the United States. Its market role centers on combining retail financial services with relationship-based commercial banking and advisory capabilities, making it an important participant in Canada’s banking system and a significant provider of integrated financial services across North America.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
This company does not file structured financial statements with the U.S. SEC, so quarterly figures aren't available from our filings-based data engine. Annual figures shown here come from the sources that do cover it.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 6.22
Total Equity: $46.41B
Shares: 983,547,258
Total Debt: $0.00
Cash: $8.92B
EBITDA: N/A
Total Debt: $0.00
Cash: $8.92B
Revenue: $21.16B
Revenue: $21.16B
Revenue: $21.16B
Total Equity: $46.41B
Tax Rate: 22.7%
Equity: $46.41B
Total Debt: $0.00
Cash: $8.92B
Current Liabilities: N/A
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $46.41B
Shares: 983,547,258
Shares: 983,547,258
CapEx: $0.00
Shares: 983,547,258
Stock Price: $114.93
Net Income: $6.12B
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 25, 2026 1:30am (43d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $14.5B | $15.9B | $16.9B | $18.6B | $21.2B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Expenses | $4.9B | $5.4B | $5.7B | $4.5B | $7.0B |
| Operating Income | — | — | — | — | — |
| Net Income | $4.7B | $4.5B | $3.6B | $5.2B | $6.1B |
| EBITDA | — | — | — | — | — |
| EPS | $5.07 | $4.87 | $3.76 | $5.30 | $6.26 |
| EPS (Diluted) | $5.06 | $4.85 | $3.76 | $5.29 | $6.22 |
Balance Sheet (Annual)
Last updated: Aug 14, 2026 10:43am (54d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $24.9B | $22.7B | $15.0B | $6.2B | $8.9B |
| Total Current Assets | — | — | — | — | — |
| Total Assets | $603.5B | $679.8B | $702.9B | $750.7B | $804.7B |
| Current Liabilities | — | — | — | — | — |
| Long-Term Debt | — | — | — | — | — |
| Total Liabilities | $570.5B | $643.5B | $664.6B | $708.2B | $758.3B |
| Total Equity | $33.0B | $36.3B | $38.3B | $42.5B | $46.4B |
| Retained Earnings | $18.6B | $20.8B | $21.9B | $24.1B | $26.3B |
Cash Flow (Annual)
Last updated: Aug 5, 2026 9:45am (63d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$2.4B | $16.1B | $8.6B | $7.9B | $9.8B |
| Capital Expenditure | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Acquisitions (net) | — | -$2.2B | — | — | — |
| Net Debt Issued / (Repaid) | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — |
| Net Change in Cash | -$6.4B | -$2.2B | -$7.6B | -$8.7B | $2.7B |
Growth Trends (YoY %)
Last updated: Aug 25, 2026 1:30am (43d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +9.1% | +6.8% | +9.8% | +13.8% |
| Gross Profit Growth | — | — | — | — |
| Operating Income Growth | — | — | — | — |
| Net Income Growth | -3.3% | -19.7% | +42.4% | +18.5% |
| EBITDA Growth | — | — | — | — |
Dividend History (Last 20)
Last updated: Aug 19, 2026 8:03pm (49d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-06-29 | $0.75 | — | — | — |
| 2026-03-27 | $0.77 | — | — | — |
| 2025-06-27 | $0.71 | — | — | — |
| 2025-03-28 | $0.68 | — | — | — |
| 2024-12-27 | $0.67 | — | — | — |
| 2024-09-27 | $0.67 | — | — | — |
| 2024-06-28 | $0.66 | — | — | — |
| 2024-03-27 | $0.66 | — | — | — |
| 2023-12-27 | $0.68 | — | — | — |
| 2023-09-27 | $0.64 | — | — | — |
| 2023-06-27 | $0.66 | — | — | — |
| 2023-03-27 | $0.62 | — | — | — |
| 2022-12-23 | $0.62 | — | — | — |
| 2022-09-27 | $0.60 | — | — | — |
| 2022-06-27 | $0.64 | — | — | — |
| 2022-03-25 | $0.32 | — | — | — |
| 2021-09-27 | $0.29 | — | — | — |
| 2021-06-25 | $0.30 | — | — | — |
| 2021-03-26 | $0.29 | — | — | — |
| 2020-12-24 | $0.28 | — | — | — |
Deep Analysis
Risk : Reward — upside vs downside from this company's own quarters
Computed 2026-09-10 02:02A +1σ run of quarters pays -19%; a −1σ run costs 37%. Ratio -0.5:1 (μ 12.6%, σ 4.3% floored by sector, 16 pairs).
Older method (repeat-worst-quarter): 0.4 : 1
| Case | Growth | Margin | Fair value | vs price ($114.93) |
|---|---|---|---|---|
| Bull — recovery | +25% | 35.0% | $130.29 | +13% |
| Base — stabilizes | +16% | 30.9% | $92.18 | -20% |
| Bear — keeps slipping | +8% | 26.3% | $62.74 | -45% |
| Stress — last quarter repeats | +10% | 30.9% | $75.82 | -34% |
| Upside — a +1σ run of quarters (v2) | +17% | 30.9% | $93.59 | -19% |
| Stress — a −1σ run of quarters (v2) | +8% | 30.9% | $72.51 | -37% |
Narrative Economics
market-narrative step).
Growth Outlook
Analyzed 2026-08-25 01:52The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
The raw numbers tell a straightforward story: CM printed $21.16B revenue and $6.12B net income in fiscal 2025, up from $16.94B/$3.63B just two years ago. That's 25% revenue growth and 69% earnings growth over two years for a Big Five bank — which is objectively anomalous. Net margin expanded from 21.4% (FY23) to 28.9% (FY25). ROE at 13.2% is respectable but ROA at 0.76% is thin, reflecting the leverage inherent in banking. The 18.5x trailing P/E and 2.44x P/B are not obviously cheap for a Canadian bank — historical Canadian bank P/Es cluster in the 10-13x range, and 2.4x P/B is at the higher end of the decade. The 2.54% dividend yield is actually below the 4%+ the narrative model claims, which suggests either a stale yield figure elsewhere or that the stock has already re-rated meaningfully.
Here the models diverge sharply and I side with the skeptics. The Valuation Synthesis calls $150 fair value (+30.7%) but flags method disagreement — that's the composite forcing a growth extrapolation onto a bank at cyclical peak earnings. The Thesis Evaluation (-18, bearish) and Market Forces (neutral, transitory cyclical) are the more honest reads. The 29.9% earnings CAGR is not a durable rate for a diversified Canadian bank — it reflects (1) normalization off the FY23 trough where NI collapsed to $3.63B on elevated PCLs and U.S. commercial real estate marks, and (2) an unusually favorable NIM environment as rates peaked. Both tailwinds reverse. The Bank of Canada is cutting; NIMs compress mechanically; and PCLs at Canadian banks are running below through-cycle averages. Applying a normalized ~11x P/E to ~$5.5B mid-cycle earnings gets you closer to $65-70/share, not $150. Even generous assumptions — 13x on current $6.12B NI — yield ~$87/share.
A contrarian to my own skepticism would argue: CM has structurally repositioned. The 2017 PrivateBancorp acquisition is now digested, the U.S. commercial book has been de-risked post-2023 write-downs, wealth management is growing, and the market has correctly priced a higher normalized earnings base. The Canadian oligopoly (Big Five plus National) is genuinely durable and Basel III capital rules make new entry impossible. Fair enough — but this argues for 12-13x on real earnings, not 18.5x. The re-rating from $50 (2023) to $115 has already happened; you're not buying a discount, you're paying for the recovery. The narrative model's claim of a "23% discount" contradicts the actual multiples — CM is not trading at 0.75x P/B, it's at 2.44x. That's a significant data inconsistency in the narrative layer that should not be papered over.
Data quality caveats: debt_to_equity of 0 is nonsensical for a bank (the model simply doesn't handle bank balance sheets — deposits aren't captured as debt), ROA is technically correct but not comparable to non-financials, and the quarterly revenue trajectory is absent, which matters because Q4 2025 NIM trajectory would tell us whether the peak is already rolling over. I'd want to see the sequential quarters before committing capital. My verdict: the Synthesis is wrong to call this undervalued at $115. Mid-cycle fair value is $95-105, meaning CM is modestly overvalued to fairly valued at current levels, with asymmetric downside if PCLs normalize toward 40-50bps and NIMs compress 15-20bps as expected in 2026. The dividend and buyback provide a floor but not a catalyst. I dissent from the composite fair value; I partially align with the bearish Thesis Evaluation and Market Forces reads. This is a hold-if-owned, don't-chase name — wait for a 15-20% pullback on the inevitable earnings miss when provisions normalize.
GPT Reading
The first thing that jumps out is how messy the “cheap Canadian bank” framing is against the actual numbers. CIBC has clearly improved earnings power since the 2023 trough: net income went from $3.63B in 2023 to $5.17B in 2024 and $6.12B in 2025, while revenue rose from $16.94B to $21.16B over the same period. That is a very strong two-year rebound, and a 28.9% net margin for a diversified bank is healthy. But the stock is not priced like a cyclical recovery still in progress; at $114.93 and a stated 18.5x P/E with 2.44x book, it is priced like a bank with sustainably high-teens returns and unusually low risk. The problem is that the reported ROE is only 13.2% on $46.41B of equity, which does not justify 2.4x book in a mature banking franchise. A simple bank sanity check is P/B roughly equals ROE divided by cost of equity-adjusted growth expectations; unless you think CIBC can push and hold ROE materially above 15% with benign credit, this multiple is rich.
The income statement trend is better than the valuation implies, not better than history. Revenue has compounded from $14.54B in 2021 to $21.16B in 2025, about 9-10% annualized off the raw figures, but net income is only now modestly above the $4.67B earned in 2021 after dipping to $4.52B in 2022 and $3.63B in 2023. In other words, earnings have recovered, not structurally re-rated. If I compare the current market cap of $104.91B to 2025 net income of $6.12B, shareholders are paying a full multiple for what is still plainly a cyclical earnings high-water mark unless proven otherwise. Operating cash flow of $9.83B supports the idea that the franchise is real and cash generative, but for banks OCF is not the valuation anchor that it is for industrials; book value growth and through-cycle ROE are. On that basis, CIBC looks expensive rather than undervalued.
There is also a contradiction in the supplied narrative signals worth calling out. One layer describes the stock as a value play at a P/B discount and leaning on a 4%+ dividend yield, but the actual canonical metrics show 2.44x book and only a 2.54% dividend yield. I would trust the hard metrics over the narrative wrapper. If 2.44x book is the right figure, then the market is assigning CIBC a premium valuation more akin to a high-quality compounder than a plain vanilla mature bank. That makes the bar for execution much higher. With only 0.76% ROA and 13.2% ROE, I do not see evidence of a premium franchise earning profile. The market may be extrapolating the 2024-2025 earnings rebound too aggressively, especially if that rebound was helped by favorable spread dynamics or reserve normalization that do not repeat.
The best case against my view is straightforward: maybe 2023 was the abnormal year, 2025 is the new base, and CIBC deserves to trade above traditional Canadian bank multiples because the business mix and capital generation have improved. Revenue growth of 13.8% year over year and earnings growth of 18.5% are not trivial for a bank this size, and moving from $14.54B of revenue in 2021 to $21.16B in 2025 is materially better than “no growth.” If management can keep net income around or above $6B while compounding book value, then an 18x earnings multiple could compress naturally as earnings catch up. A bull would also argue that a $46.41B equity base against a $104.91B market cap is acceptable if the market believes ROE can inflect higher from 13% toward the mid-teens and stay there. I weigh that less heavily because banks rarely deserve the benefit of the doubt at peak-ish profitability; credit and margin normalization usually show up after investors have already capitalized the good years.
What would change my mind is evidence that this is not just earnings normalization but a real profitability step-up. Specifically, I would want to see another year with net income at or above $6.2B alongside book value growth and ROE sustained above 15%, not just one year at 13.2%. If that happens without the P/B falling, the premium may be earned. Conversely, if earnings slip back toward $5.0B-$5.3B as rates and credit costs normalize, the stock quickly looks mispriced at nearly 18.5x earnings and 2.4x book. For now I think fair value sits meaningfully below the current quote unless the next 12-18 months prove this bank has a higher through-cycle earnings base than its recent history suggests.
Grok Reading
The numbers tell a recovery story that has already been paid for. CIBC’s revenue climbed from $14.54B in 2021 to $21.16B in 2025—an 11.8% CAGR—while net income swung from a $3.63B trough in 2023 to $6.12B in 2025, producing a 29.9% earnings CAGR that is almost entirely a two-year bounce off credit and rate stress. Operating cash flow of $9.83B against that $6.12B of net income looks healthy, ROE has settled at 13.2%, and net margin prints an eye-catching 28.9%. None of that is imaginary. What stands out is the multiple attached to it: 18.5x earnings and 2.44x book at $114.93. For a diversified Canadian bank whose ROA is still a thin 0.76% and whose dividend yield is only 2.54%, those are peak-cycle prices on mid-cycle economics. The 2023–25 surge is being capitalized as if it is the new run-rate rather than the unwind of prior provision and NIM pressure.
The internal model conflict is the tell. The valuation composite spits out $136–$150 and an “undervalued” flag, yet simultaneously admits methods disagree and that the market is embedding more growth than the projections support. The thesis layer is clearer and better grounded: a −18 score driven by mechanical margin compression and unavoidable provision normalization, against an oligopoly and wealth-management bid that cannot fully offset a flattening curve and latent commercial/U.S. credit risk. Historical Canadian bank P/Es clustered in the 11–13x zone; 18.5x is a 50%+ premium that only works if the $6.12B earnings base compounds from here without mean-reversion in credit costs. Revenue confidence is high on the trailing print, but the macro tape is labeled headwinds and the market-forces layer correctly flags the recent outperformance as cyclical, not structural.
The strongest case against this read is straightforward: CIBC is still a Big Five oligopoly member with durable deposit funding, a wealth franchise that is gaining share, and a clean-looking balance-sheet snapshot (equity $46.41B, cash $8.92B). If the 13.2% ROE is sustainable and management can keep growing tangible book at mid-to-high single digits while defending the dividend, a 2.4x P/B is defensible under a 9% cost of equity and ~6% growth—exactly the arithmetic that gets you to the composite’s $136 fair value. A bull would also note that the stock has often traded at a discount to Royal and TD, so 18.5x may simply be catch-up rather than froth, and that 13.8% recent revenue growth plus 18.5% earnings growth give the multiple something real to stand on. I weigh that less heavily because the same data show earnings power was $3.63B only two years ago; mean-reversion in provisions does not require a recession, only normalization, and the 2.54% yield offers limited cushion if multiples compress back toward the historical band.
What would flip the view is concrete: two consecutive quarters of stable or expanding net interest margin alongside provisions that stay below the 2024–25 run-rate, or a clear path to ROE sustainably above 15% that would re-justify 2.4x book. Conversely, a 100 bp rise in the credit-loss ratio or a sub-12% ROE print would confirm the multiple is wrong-footed and push fair value toward the low $90s.
Qwen Reading local experiment · off-panel
The number that decides this case is the P/E relative to the Canadian Big Five regime, not the absolute earnings level. CIBC's 2025 net income of $6.12B on $21.16B revenue (28.9% net margin) is a strong print, and the revenue ramp from $14.54B (2021) to $21.16B (2025) — roughly 10% CAGR with the most recent year accelerating to 13.8% YoY — is genuinely above the sector norm. But at $104.91B market cap, the stock trades at 17.1x trailing earnings and 2.26x book ($46.41B equity). The historical P/E range for Canadian Big Five banks, as the briefing's own thesis layer notes, is 11–13x. Even crediting CIBC's above-average 13.2% ROE (NI/equity checks out at $6.12B/$46.41B) and the accelerating revenue, a 14–16x multiple is the upper bound of what I'd pay. At 17x, the market is paying for a growth story that the balance sheet does not yet confirm.
The 2023 earnings dip to $3.63B (down 19.7% from 2022's $4.52B) on a year where revenue actually grew 6.8% is the tell that something non-recurring hit the P&L — elevated provisioning, a restructuring charge, or a specific credit loss. The 2024 rebound to $5.17B and 2025's $6.12B confirm the underlying business is intact. The "earnings CAGR of 29.9%" in the momentum block is an artifact of anchoring to that depressed 2023 base; the true four-year CAGR from 2021's $4.67B is closer to 7%. The "FCF CAGR of 6.7%" and the blank free-cash-flow line are not decision-useful for a bank — operating cash flow of $9.83B is balance-sheet mechanics (deposit flows, loan origination), not a cash-generation metric. The debt-to-equity of zero and blank total-debt line are the same artifact: a bank's liabilities are deposits, not borrowings, and the data source simply does not map them. I set all of these aside.
The prior models disagree with each other and, in different directions, with the raw data. The Valuation Synthesis lands at $136–$150, implying 22–24x 2025 earnings — a multiple I cannot justify for a Canadian bank even with 13.2% ROE. The Thesis Evaluation scores −18 and calls this "peak-cycle multiples" at "20x P/E," which overstates the actual 17.1x and overstates the premium to the 11–13x range (it is 30–55%, not the "50–70%" the thesis claims). The Market Forces "Neutral" call and the "transitory cyclical factors" language are closer to the truth but lack specificity. The Narrative layer's "steady-compounder" framing with "minimal" intensity is the most honest read: this is a dividend-and-capital-return stock, not a growth story, and the 2.54% yield is modest by the group's standards.
The strongest case against my mild overvaluation read is the revenue acceleration. Thirteen-point-eight percent YoY revenue growth in 2025, on top of 9.8% in 2024 and 6.8% in 2023, is not the profile of a mature, margin-compressed bank. If that growth is driven by wealth management fee income and capital markets volume (the bull thesis's "Wealth Management Momentum" at weight 42), it is more durable than NIM-driven growth and supports a higher multiple. A 16x P/E on $6.12B earnings is $104B, or roughly $114 — exactly where the stock sits. So the bull case is: you are not overpaying if the 2025 earnings are the floor, not the peak, and the revenue trend continues. I weigh this seriously, but the 2.26x P/B still requires ROE to hold above 13% for the multiple to be justified, and the "Macro Headwinds" signal in the briefing — flattening yield curves, anemic mortgage growth — is a real threat to NIM that would compress the top line and, with it, the earnings base the multiple sits on.
What would change my mind: a quarterly print showing revenue growth decelerating below 8% YoY while net margin compresses below 25% would confirm the NIM-compression bear case and push fair value toward $95–$100, making the overvaluation more than 10%. Conversely, if the next two quarters show revenue growth holding above 12% with ROE expanding toward 14–15% (implying the 2023 dip was truly one-time and the capital base is working harder), a 16–17x multiple becomes defensible and the stock is fairly valued at current levels. The specific number to watch is the quarterly net interest income line, which the briefing does not break out — without it, I cannot separate NIM-driven growth from fee-driven growth, and that distinction is the entire valuation question.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
Revenue has compounded from $14.5B (2021) to $21.2B (2025), roughly 9.8% CAGR, with net income recovering from a $3.63B trough in 2023 to $6.12B in 2025 — a clean re-acceleration after the 2023 credit-cycle dip. Operating cash quality is strong: OCF/NI of 1.72x and slightly negative accruals (-0.4% of assets) suggest earnings are backed by cash, not accounting stretch. FCF of $9.83B against a $105B market cap points to a self-funding franchise that does not need capital markets to operate.
Verify before trusting this (5)
- Reconcile the 705.8M (2024) vs 983.5M (2025) diluted share count — is this a restatement, preferred conversion, or data error?
- CET1 ratio, loan-loss provisions trend, and PCL coverage vs Canadian peers (RBC, TD, BMO)
- Exposure to Canadian residential mortgages and U.S. commercial real estate (CIBC has historically had higher U.S. office CRE exposure)
- Net interest margin trajectory and deposit franchise stability
- Dividend payout ratio and buyback authorization vs regulatory capital constraints
The e2e composite pegs fair value at $136.48 (signal-adjusted $150.26), implying 19-31% upside from $114.93. The anchored-PE method drives this, which is the right lens for a mature bank where earnings power and payout matter more than DCF gymnastics. Earnings quality is good, so no haircut is warranted, and the Solid quality grade supports a deserved multiple in line with Big Six peers rather than a discount. I lean toward the $136 composite over the $150 signal-adjusted number - the latter likely overweights momentum in a rate-sensitive name where NIM direction is uncertain. Against $114.93, roughly $136 deserved gives a ~16-19% margin, which is meaningful but not the kind of gap that screams. Big Six Canadian banks periodically trade at 15-20% discounts to intrinsic value and then close them over 12-24 months as credit fears fade; that appears to be the setup here. The 4%+ yield pays you to wait, and dilution is tame. What is NOT priced in: a benign credit cycle and NIM stabilization. What IS priced in: mortgage stagnation, cost inflation, and lingering credit worry. Fair-value math is not runaway (only ~1.2x price), so I trust the anchor. This is a modest discount to a decent business - worth owning, not worth backing up the truck.
Verify before trusting this (5)
- CET1 capital ratio and trajectory
- US commercial real estate exposure and reserve coverage
- NIM guidance and deposit beta commentary
- Provision for credit losses trend vs guidance
- Efficiency ratio and cost discipline updates
The market regime is essentially neutral (score +18, VIX under 16, S&P barely off highs), so there is no risk-off wave to punish CM specifically. The narrative around Canadian banks is a low-intensity, durable 'steady compounder' archetype with minimal cult premium - meaning almost no story-driven pressure in either direction. Fundamentals, not sentiment, are setting the price here, which is exactly the setup where sentiment scores near balanced. What tilts it faintly negative is CM's 1.28 beta (unusually high for a diversified bank) combined with a 10y at 4.74% and a flattish curve - the macro overhang for NIM-sensitive lenders is a real, ordinary crosswind even in a calm tape. News flow is benign-to-quiet (a student upskilling poll, a prior AI tool award), and the recent 3% single-day drop was tagged as non-company-specific, consistent with beta drag rather than a narrative crack. Analyst tone is not shouting either way, and the 'discount to intrinsic value' framing is a fundamentals argument, not a sentiment tailwind. Net: a mild headwind from rates/beta, offset by narrative durability and a calm tape - close to balanced.
Verify before trusting this (4)
- Any shift in the Canadian yield curve or BoC rhetoric that would change the NIM narrative
- Credit-loss provisioning trend in the next quarterly print - a crack here would activate the dormant bear story
- Analyst target revisions post-earnings - divergence from the 'discount to fair value' framing
- Whether Canadian housing/mortgage data begins to inflect, which could rotate sentiment back into the group
The world is in a Canadian bank sweet spot that is late rather than early: front-end easing has restored a positively sloped curve, deposit costs are repricing down, asset prices have inflated wealth-management fee pools, and capital markets activity is healthy. All three drivers are macro-granted, not company-earned. The structural question underneath is Canadian household leverage: a mortgage stock renewing into materially higher payments caps domestic loan volume growth for years and slowly lifts provisions, which is why the long-run shape for CM is a mid-single-digit compounder with a reliable capital return rather than a growth franchise. Nothing in the technology or competitive landscape threatens the deposit-and-lending core in this window; the Big Six oligopoly and Canadian regulatory perimeter remain the moat that keeps the category's growth from being competed away.
When we made this prediction on Aug 25, 2026, CM was $117.66. We expect it to be $129.75 by Feb 2027, and we consider it great value under $105.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Aug 25, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.